These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 1533220
1. Functional expression of the human serotonin 5-HT1A receptor in Escherichia coli. Ligand binding properties and interaction with recombinant G protein alpha-subunits. Bertin B, Freissmuth M, Breyer RM, Schütz W, Strosberg AD, Marullo S. J Biol Chem; 1992 Apr 25; 267(12):8200-6. PubMed ID: 1533220 [Abstract] [Full Text] [Related]
2. Cell-specific physical and functional coupling of human 5-HT1A receptors to inhibitory G protein alpha-subunits and lack of coupling to Gs alpha. Raymond JR, Olsen CL, Gettys TW. Biochemistry; 1993 Oct 19; 32(41):11064-73. PubMed ID: 8218170 [Abstract] [Full Text] [Related]
3. Expression of the human 5-hydroxytryptamine1A receptor in Sf9 cells. Reconstitution of a coupled phenotype by co-expression of mammalian G protein subunits. Butkerait P, Zheng Y, Hallak H, Graham TE, Miller HA, Burris KD, Molinoff PB, Manning DR. J Biol Chem; 1995 Aug 04; 270(31):18691-9. PubMed ID: 7629202 [Abstract] [Full Text] [Related]
4. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats. Lejeune F, Newman-Tancredi A, Audinot V, Millan MJ. J Pharmacol Exp Ther; 1997 Mar 04; 280(3):1241-9. PubMed ID: 9067310 [Abstract] [Full Text] [Related]
5. Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy. Newman-Tancredi A, Conte C, Chaput C, Verrièle L, Audinot-Bouchez V, Lochon S, Lavielle G, Millan MJ. Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun 04; 355(6):682-8. PubMed ID: 9205951 [Abstract] [Full Text] [Related]
6. Stimulated [35S]GTP gamma S binding by 5-HT1A receptor agonists in recombinant cell lines. Modulation of apparent efficacy by G-protein activation state. Pauwels PJ, Tardif S, Wurch T, Colpaert FC. Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov 04; 356(5):551-61. PubMed ID: 9402034 [Abstract] [Full Text] [Related]
7. The GTP-insensitive component of high-affinity [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding in the rat hippocampus corresponds to an oxidized state of the 5-hydroxytryptamine1A receptor. Emerit MB, Miquel MC, Gozlan H, Hamon M. J Neurochem; 1991 May 04; 56(5):1705-16. PubMed ID: 1826520 [Abstract] [Full Text] [Related]
9. 5-HT1A receptor-mediated G protein activation assessed by [35S]GTPgammaS binding in rat cerebral cortex. Odagaki Y, Toyoshima R. Eur J Pharmacol; 2005 Oct 03; 521(1-3):49-58. PubMed ID: 16182280 [Abstract] [Full Text] [Related]
13. [3H]spiroxatrine: a 5-HT1A radioligand with agonist binding properties. Herrick-Davis K, Titeler M. J Neurochem; 1988 Feb 03; 50(2):528-33. PubMed ID: 2961850 [Abstract] [Full Text] [Related]
14. Characterization of a novel serotonin receptor subtype (5-HT1S) in rat CNS: interaction with a GTP binding protein. Zemlan FP, Schwab EF. J Neurochem; 1991 Dec 03; 57(6):2092-9. PubMed ID: 1834802 [Abstract] [Full Text] [Related]
15. Dimerization of 8-OH-DPAT increases activity at serotonin 5-HT1A receptors. Pauwels PJ, Dupuis DS, Perez M, Halazy S. Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct 03; 358(4):404-10. PubMed ID: 9826061 [Abstract] [Full Text] [Related]